CClinicalTrials.gg
CompletedNCT02544620Updated Mar 28, 2019

Out Patient Surgery for Total Knee and Hip Replacement and Unicompartmental Knee Replacement - a Feasibility Study

An observational study in Osteoarthritis, sponsored by Kirill Gromov. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-03-28.

Sponsored by Kirill Gromov · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate feasibly of outpatient Total Knee Replacement, Total Hip Replacement and Unicompartmental Knee Replacement in a modern fast-track setup. The design is as an observational prospective study, evaluating patients that fulfil discharge criteria on the day of the surgery. The investigators will further evaluate safety aspects, such a early morbidity and mortality, as well as patient satisfaction.

Read the detailed description

Fast-track total hip arthroplasty (THA), total knee arthroplasty (TKA) and Unicompartmental Knee arthroplasty (UKA) with length of stay (LOS) of 1-3 is a well established concept for treating hip and knee osteoarthritis, resulting in short reconvalescence, high patient satisfaction, and an excellent safety profile (lower or similar mortality / morbidity compared to conventional pathways with longer LOS). LOS have been significantly reduced during the past decade, and several centers have published even shorter hospitals stays: \<24 hours, with patients staying the night at the hospital but also outpatient surgery, with patients being discharged on the day of surgery.

However, these proposed pathways with extremely short LOS, are performed on very selected patients, with few details on patient satisfaction, outcome and most important patient safety. Therefore, it is not possible to draw conclusions on feasibility of outpatient THA, TKA and UKA surgery in a general and unselected population. Further on, there is a need for investigation of safety aspects of outpatient surgery in respect to mortality, morbidity, patient satisfaction and patient reported outcomes. As some, most likely healthy and younger, patients might benefit from outpatient surgery - eg discharge on the day of surgery, while others might not; the first step is to identify the patients that are suitable for outpatient THA and TKA surgery and investigate the safety aspects in respect to mortality, morbidity, patient satisfaction and patient reported outcomes.

Aim:

The aim of this study is to investigate "feasibility" and "safety" of outpatient THA, TKA and UKA surgery, respectively as follows:

Feasibility

  • Proportion of patients, that can be included in the study according to inclusion criteria stated below, and be evaluated for potential same-day discharge (I) (I = included)
  • Proportion of included patients (I), that are discharged on the day of surgery (U) and those who are not discharged and stay for >1 day (B)
  • Identify reasons for patients not being able to be discharged on the day of surgery (B)

Safety

  • risk for complications (morbidity) in group (U) compared to group (B) (are there complications that potentially could have been avoided is the patient was not discharged)
  • readmissions in group (U ) compared to group (B) within 90 days
  • mortality in group (U ) compared to group (B) within 90 days
  • patient satisfaction in group (U ) compared to group (B)
  • Patient reported outcome (Oxford knee score + range of motion for TKA and UKA group, and Oxford hip score for THA group) in group (U) compared to group (B)
  • contacts to primary sector in group (U ) compared to group (B) within 7 days.
  • use of rescue morphine (pain journal) for 7 days post op in group (U ) compared to group (B)
02

Conditions studied

  • Osteoarthritis

Browse trials for

03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 1,000 is above the median of 100 across 791 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

This is the only study on the registry with Kirill Gromov as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

  • Unselected primary THA/TKA/UKA
  • ASA score I/II
  • Can be operated as #1 or #2
  • No sleep apnea treated with CPAP

Inclusion criteria

  • Unselected primary THA/TKA
  • ASA score I/II
  • Can be operated as #1 or #2
  • No sleep apnea treated with CPAP

Exclusion criteria

Exclusion Criteria:

  • Selected primary THA/TKA
  • ASA score > 2
  • Cannot be operated as #1 or #2
  • Sleep apnea treated with CPAP
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (actual)
Patient registry
No

Groups and cohorts

  • Total Hip arthroplasty

    * Unselected primary THA * American Society of Anesthesiologists (ASA) score I/II * Can be operated as #1 or #2 * No sleep apnea treated with Continuous positive airway pressure (CPAP)

    Other: Does fulfil of discharge criteria on the day of the surgery · Other: Does not fulfil of discharge criteria on the day of the surgery

  • Total Knee arthroplasty

    * Unselected primary TKA * American Society of Anesthesiologists (ASA) score I/II * Can be operated as #1 or #2 * No sleep apnea treated with Continuous positive airway pressure (CPAP)

    Other: Does fulfil of discharge criteria on the day of the surgery · Other: Does not fulfil of discharge criteria on the day of the surgery

  • unicompartmental knee arthroplasty

    * Unselected primary UKA * American Society of Anesthesiologists (ASA) score I/II * Can be operated as #1 or #2 * No sleep apnea treated with Continuous positive airway pressure (CPAP)

    Other: Does fulfil of discharge criteria on the day of the surgery · Other: Does not fulfil of discharge criteria on the day of the surgery

Interventions

  • OtherDoes fulfil of discharge criteria on the day of the surgery
  • OtherDoes not fulfil of discharge criteria on the day of the surgery
06

What researchers measure

Primary outcomes

  1. Fulfilment of same day discharge criteria

    On the days of surgery following discharge criteria are continuously evaluated: * \< 500 ml intraoperative blood loss * Back in patient ward \<15.00 * Received instruction from physiotherapist and is safely mobilized * No clinical symptoms of anemia * Pain \<3 while resting, \<5 during exercise. * Spontaneous urination * Post op x-ray is performed and approved * Relatives or friends with patient for \>24 hours * Motivated and accepts same day discharge * Standard discharge criteria fulfilled * Can be discharged before 20.00 If all of the above criteria are fulfilled, the patient can be discharged

    Time frame: 12 hours

Secondary outcomes

  1. Readmissions

    Time frame: 3 months

  2. Patient reported satisfaction

    OKS (Oxford Knee score) and ROM (Range og motion) for TKA and UKA, OHS for THA

    Time frame: 3 months

  3. Use of rescue morphine

    Time frame: 7 days

07

Study locations

1 site
  • Hvidovre Hospital
    Hvidovre, 2650, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02544620
Lead sponsor
Kirill Gromov
Collaborators
Rigshospitalet, Denmark, Vejle Hospital, Holsterbro Sygehus, DK
Responsible party
Kirill Gromov (MD, PhD, Hvidovre University Hospital) — Sponsor-investigator
First posted
Sep 9, 2015
Start date
Sep 2015
Primary completion
Aug 31, 2018
Completion
Dec 31, 2018
Last update
Mar 28, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion